Feature | August 11, 2014

August 11, 2014 — Imaging experts from the American Society of Echocardiography (ASE) released a paper, "Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: A Focused Update from the American Society of Echocardiography,” to help clinicians optimize and demystify the use of ultrasound contrast media in medical imaging. This new guideline aims to expand the use of ultrasound enhancing agents in patient testing, particularly in new and growing areas of cardiovascular care.


The writing group for this updated guideline was chaired by Thomas R. Porter, M.D., FASE, the Theodore F. Hubbard Distinguished Chair of Cardiology at the University of Nebraska Medical Center, in Omaha, Neb. Porter noted that there is “a significant need for sonographers and physicians to be updated on software and techniques that are available to enhance technically difficult echoes, which are most common in overweight patients or those in critical care units who cannot be easily positioned for optimal imaging. This enhancement not only allows sonographers to better detect myocardial ischemia at rest and during stress echocardiography, but also is useful in enhancing Doppler signals and assessing intra-cardiac masses.”


Many technological and clinical advances have occurred since the publication of the original ASE document in 2001, “Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: Recommendations of the American Society of Echocardiography Council on Cardiac Sonography,” necessitating the need for this update to ensure that clinicians are aware of the new options.  The addition of these intravenous agents has been proven to greatly enhance sub-optimal images and lower the need for repeat imaging studies and thus provide more efficient patient care.


While ultrasound enhancing agents have been commercially available for more than two decades, it is estimated that less than 10 percent of all echocardiograms utilize this valuable tool, despite the fact that at least 20 percent of all echoes are believed to be sub-optimal and would benefit from enhancement. Ultrasound enhancing agents are underutilized today for a wide variety of reasons; both patients and clinicians are often reluctant to use ultrasound contrast because they mistakenly associate it with the contrast agents used for computed tomography (CT) and magnetic resonance imaging (MRI).


While those “classic” contrast agents use ionizing radiation and nephrotoxic agents, ultrasound contrast does not contain either of these, and has a very low incidence of harmful side effects or adverse events. According to Porter, this paper “will help sonographers to better utilize ultrasound enhancing agents and build programs at their institutions by providing important information on the safety and efficacy of ultrasound enhancement in a wide variety of clinical situations.”


In conjunction with the publication of the guideline document, Porter will conduct a live webinar, including a question and answer section, on Sept. 10, 2014 at 1 p.m. ET, which will be available for free to all ASE members and other clinicians for a fee of $25. To facilitate education for those who cannot attend the live webcast, an archived version of this webinar will be available on www.ASEUniversity.org to those who pre-register.


For more information: www.onlinejase.com, www.asecho.org/guidelines


Related Content

Mercy Hospital Joplin, Toshiba, Aplio 300 Platinum ultrasound, tornado disaster
News | Ultrasound Imaging| July 30, 2015
After a tornado decimated the hospital only four years ago, Mercy Hospital Joplin in Joplin, Missouri, reopened its...
Guerbet, acquisition, Mallinckrodt, CMDS business, contrast media, CT, MRI
News | Contrast Media| July 29, 2015
Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast...
Epsilon Imaging, EchoInsight, ASE 2015, cardiac ultrasound image analysis
News | Cardiovascular Ultrasound| July 29, 2015
Epsilon Imaging Inc. announced that several studies were presented at the American Society of Echocardiography (ASE)...
Konica Minolta, Blue Moon Lifecycle Solutions, ultrasound, Sonimage, P3, HS1

Sonimage HS1 image courtesy of Konica Minolta

Technology | July 15, 2015
Konica Minolta Medical Imaging announced new Blue Moon Lifecycle Solutions designed to help customers minimize downtime...
Mindray, TE7 Touch Enabled Ultrasound System, point of care, POC
Technology | July 14, 2015
Mindray announced the release of its TE7 Touch Enabled Ultrasound System, which supports rapid and confident evaluation...
Accuro, handheld ultrasound, Rivanna Medical, spinal anesthesia guidance, FDA

Accuro image courtesy of Rivanna Medical

Technology | July 14, 2015
Rivanna Medical announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market...
ASE, echocardiography, hypertension, document, EACVI, JASE, Thomas H. Marwick
Feature | Cardiovascular Ultrasound| July 07, 2015
A new document from the American Society of Echocardiography (ASE) provides detailed guidance for clinicians on how to...
Feature | Cardiovascular Ultrasound| July 07, 2015 | Dave Fornell, DAIC Editor
Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015 American Society of...
Summit Imaging, Summit Imaging Mobile, ultrasound, rapid response, application
Technology | June 29, 2015
Summit Imaging announced the release of Summit Imaging Mobile, the mobile version of its comprehensive online support...
Videos | Cardiovascular Ultrasound| June 29, 2015
Interview at the American Society of Echocardiography (ASE) annual meeting with Federico Asch, M.D., M.D., FACC, FASE
Overlay Init